Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy

Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Placebo to match filgotinib Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials